This study is the first to reveal the EOGT-HEY1-SLC7A11 regulatory axis, clarifying the role of EOGT in inhibiting ferroptosis and promoting tumor proliferation in HCC, providing new potential therapeutic targets and strategies for the treatment of HCC (98). Here, SLC7A11 is linked to neoplasm.